(1)
Risk Assessment of Cyclophosphamide and Mycophenolate Mofetil After Induction Treatment of Lupus Nephritis: A Single Center Quasi-Experimental Study. Chatt Maa Shi Hosp Med Coll J 2023, 22 (1), 28-32. https://doi.org/10.3329/cmoshmcj.v22i1.67831.